Subscribe To
Vaxcyte to Present at the SVB Securities Global Biopharma Conference
SAN CARLOS, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 3:00 […] The post Vaxcyte to Present at the SVB Securities Global Biopharma Conference appeared first on ForexTV...
Read More
Posted: Feb 7 2023, 21:05
Author Name: forextv
Views: 103111